Pilsicainide

DB12712InvestigationalSmall molecule

Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.

Chemical structure of Pilsicainide
Mechanism
Curator reviewed
Formula / weight
C17H24N2O · 272.392 g/mol (avg)
Also known as
Pilzicainide

Resolves to

Compound
UNIIAV0X7V6CSECAS88069-67-4ChEMBLCHEMBL163238ChEBI135127PubChem4820KEGGD08377
Structure
InChIKeyBCQTVJKBTWGHCX-UHFFFAOYSA-NSMILESCC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2
Targets
Q14524SCN5AQ12809KCNH2Q13936CACNA1CP28074PSMB5
Transporters
O95342ABCB11

What you can answer from here — as of August 30, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
515Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pilsicainide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In